Suppr超能文献

微血管减压术后无效的面肌痉挛患者该如何处置:期待延迟缓解还是早期再手术?

What Should We Do for Those Hemifacial Spasm Patients Without Efficacy Following Microvascular Decompression: Expectation of Delayed Relief or Early Reoperation?

机构信息

Department of Neurosurgery, XinHua Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

Department of Neurosurgery, XinHua Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China.

出版信息

World Neurosurg. 2018 Feb;110:e897-e900. doi: 10.1016/j.wneu.2017.11.118. Epub 2017 Nov 28.

Abstract

BACKGROUND

Although microvascular decompression (MVD) has been widely accepted as an effective treatment for hemifacial spasm (HFS), some patients may experience delayed relief instead of immediate improvement after the surgery. The need for and timing of repeat MVD has been controversial to date; thus, we conducted the present study with emphasis on those unrelieved patients.

METHODS

Between January 2010 and December 2014, 3095 patients with idiopathic HFS were treated with MVD at XinHua Hospital, Shanghai Jiaotong University School of Medicine. Among these patients, 174 (5.6%) reported no symptom relief. Those patients without immediate relief were the focus of this study, and all were reevaluated at 2 years after MVD surgery.

RESULTS

Among these 174 patients, 96 underwent redo MVD within 1 week of the first procedure (early MVD redo group), 19 underwent redo between 3 and 12 months after the first procedure (late MVD redo group), and 59 were observed (observation group). In the early redo MVD group, immediate improvement was reported by all patients except 1, who did not experience symptom relief until 3 months later. In the later redo MVD group, immediate symptom improvement was reported by 14 of 19 patients. By the end of the 2-year follow-up period, 1 recurrence occurred in the early redo MVD group, no changes occurred in the later MVD group, and 9 patients improved in the observation group. Ultimately, the final rates of symptom relief were 99.0% in the early redo MVD group, 73.7% in the later redo MVD group, and 15.3% in the observation group (P < 0.01). In the early redo MVD group, postoperative courses showed no significant differences between the first and the second operations. In the later redo MVD group, 1 patient developed a mild facial palsy and 1 had a cerebrospinal fluid leak.

CONCLUSIONS

Our findings demonstrate that MVD is the most effective treatment for patients with HFS. An early reoperation is easier and safer than a later reoperation and may improve the likelihood of immediate relief.

摘要

背景

微血管减压术(MVD)已被广泛认为是治疗面肌痉挛(HFS)的有效方法,但部分患者术后可能不会立即缓解,而是延迟缓解。迄今为止,对于是否需要重复 MVD 以及何时重复 MVD 一直存在争议,因此我们进行了这项研究,重点关注那些未缓解的患者。

方法

2010 年 1 月至 2014 年 12 月,上海交通大学医学院新华医院对 3095 例特发性 HFS 患者行 MVD 治疗。其中 174 例(5.6%)患者报告无症状缓解。这些无立即缓解的患者是本研究的重点,所有患者均在 MVD 手术后 2 年进行再次评估。

结果

在这 174 例患者中,96 例在第一次手术后 1 周内行再次 MVD(早期 MVD 再次手术组),19 例在第一次手术后 3-12 个月内行再次 MVD(晚期 MVD 再次手术组),59 例患者行观察(观察组)。在早期再次 MVD 组中,除 1 例患者在 3 个月后才出现症状缓解外,所有患者均立即改善。在晚期再次 MVD 组中,19 例患者中有 14 例立即改善症状。在 2 年随访期末,早期再次 MVD 组发生 1 例复发,晚期再次 MVD 组无变化,观察组有 9 例患者改善。最终,早期再次 MVD 组症状缓解率为 99.0%,晚期再次 MVD 组为 73.7%,观察组为 15.3%(P<0.01)。在早期再次 MVD 组中,第一次和第二次手术的术后病程无显著差异。在晚期再次 MVD 组中,1 例患者出现轻度面瘫,1 例患者发生脑脊液漏。

结论

我们的研究结果表明,MVD 是治疗 HFS 患者最有效的方法。早期再次手术比晚期再次手术更容易且更安全,并且可能提高立即缓解的可能性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验